Bangladesh vs Developing regions: Proportion of the target population who received a 3rd dose of
Bangladesh
97.0%
in 2024
Developing regions
66.0%
in 2024
Bangladesh rank
11th
Developing regions rank
24th
Proportion of the target population who received a 3rd dose of over time
- Bangladesh
- Developing regions
How they compare
Bangladesh currently reports 97.0% against 66.0% in Developing regions, a difference of 31.0%.
That makes Bangladesh's figure about 1.5 times Developing regions's.
Across all 10 years both countries report, Bangladesh has been ahead every year.
Bangladesh ranks 11th and Developing regions ranks 24th of 157 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.2% | 41.0% | 47.2% | Bangladesh |
| 2020s | 97.4% | 56.4% | 41.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Bangladesh or Developing regions?
- Bangladesh, at 97.0% against 66.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Bangladesh and Developing regions?
- 31.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Developing regions?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Developing regions rank globally for proportion of the target population who received a 3rd dose of?
- Bangladesh ranks 11th and Developing regions ranks 24th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.